<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-07 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-07/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-07"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-07 ä»Šæ—¥ç­›é€‰å‡º 74 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-07T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-07T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week452025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-07"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-07 ä»Šæ—¥ç­›é€‰å‡º 74 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-07T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-07T00:00:00+00:00"><meta itemprop=wordCount content="2131"><meta itemprop=keywords content="Research,Daily,Week452025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-07"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-07 ä»Šæ—¥ç­›é€‰å‡º 74 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-07</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-07T00:00:00Z>2025-11-07</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-07>ğŸ“… Daily Report - 2025-11-07</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>74</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
&ldquo;åŸºå› æ˜¾å¾®é•œ"NanoSeqæŠ€æœ¯çµæ•åº¦æå‡ç™¾å€ï¼Œé¦–æ¬¡ç»˜åˆ¶å¥åº·äººç™Œç—‡çªå˜å…¨æ™¯å›¾ï¼›Perturb-seqæŠ€æœ¯åœ¨ä½“åº”ç”¨é¦–ç§€ï¼Œå¼•é¢†å•ç»†èƒ2.0æ—¶ä»£ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«è°ƒæ§æœºåˆ¶ï¼ˆè¿åŠ¨ã€è›‹ç™½ã€ä»£è°¢ç‰©ç­‰è§’åº¦ï¼‰ã€‚</li><li>éå°ç»†èƒè‚ºç™Œï¼ˆNSCLCï¼‰çš„å•ç»†èƒã€ç©ºé—´è½¬å½•ç»„å­¦åŠé£é™©åˆ†å±‚ã€‚</li><li>è‚¿ç˜¤å…ç–«ç ”ç©¶æ–°çƒ­ç‚¹ï¼ˆå¼•æµæ·‹å·´ç»“ã€CD8 Tç»†èƒåŠŸèƒ½ï¼‰ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ–°ä¸€ä»£çº³ç±³æµ‹åºï¼ˆNanoSeqï¼‰å®ç°å¤šå…‹éš†æ ·æœ¬ä½“ç»†èƒçªå˜çš„æ— åå€šæ£€æµ‹ã€‚</li><li>æé™Metaåˆ†æï¼ˆLimit meta-analysisï¼‰æä¾›å°æ ·æœ¬æˆ–æ½œåœ¨åå€šä¸‹çš„ç¨³å¥æ•ˆåº”ä¼°è®¡ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p></blockquote><ul><li><strong>GSE308237/GSE307892/GSE307740/GSE298534/GSE298465</strong>ï¼šé€šè¿‡æ–°å‹CHANGE-seq-BEæŠ€æœ¯ï¼Œå®ç°å¯¹Casä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨åŸºå› ç»„è„±é¶æ´»æ€§çš„çµæ•ä¸”æ— åå€šçš„ä½“å¤–é«˜é€šé‡åˆ†æï¼Œä¸ºåŸºå› ç¼–è¾‘çš„å®‰å…¨æ€§è¯„ä¼°å¸¦æ¥çªç ´ã€‚</li></ul><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>å…ç–«ä¸ç‚ç—‡</strong>ï¼šGSE294668ç ”ç©¶äº†è¿‘çº¢å¤–å…‰ç”Ÿç‰©è°ƒèŠ‚ï¼ˆPBMï¼‰åœ¨å°é¼ è¿‡æ•æ€§å“®å–˜æ¨¡å‹ä¸­ï¼Œé€šè¿‡è°ƒæ§Th2ç»†èƒå› å­å’Œç‚ç—‡ç»†èƒæµ¸æ¶¦çš„æ²»ç–—æ½œåŠ›ã€‚</li><li><strong>åŸºå› è°ƒæ§ä¸ç–¾ç—…</strong>ï¼šGSE270168/GSE270169æ­ç¤ºäº†GAPDHåœ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ï¼ˆAMLï¼‰ä¸­è°ƒæ§è½¬å½•ç¨³å®šæ€§ã€è›‹ç™½ç¿»è¯‘åŠç»†èƒå¢æ®–çš„å…³é”®ä½œç”¨ã€‚</li><li><strong>åŸºå› ç¼–è¾‘æŠ€æœ¯</strong>ï¼šGSE308237ç­‰ç³»åˆ—ç ”ç©¶å±•ç¤ºäº†CHANGE-seq-BEåœ¨è¯„ä¼°åŸºå› ç¼–è¾‘å·¥å…·ï¼ˆå¦‚Cas9å’Œç¢±åŸºç¼–è¾‘å™¨ï¼‰è„±é¶æ•ˆåº”æ–¹é¢çš„åˆ›æ–°åº”ç”¨ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>CHANGE-seq-BE</strong>ï¼šä¸€ç§æ–°å‹é«˜é€šé‡æŠ€æœ¯ï¼Œç”¨äºåŒæ—¶ã€çµæ•ä¸”æ— åå€šåœ°åˆ†æåŸºå› ç¼–è¾‘å·¥å…·çš„åŸºå› ç»„è„±é¶æ´»æ€§ã€‚</li><li><strong>PRO-seq/mRNA-seq</strong>ï¼šç”¨äºè§£æçŠ¬ç±»å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ï¼Œä»¥åŠå¿«é€Ÿæ¿€æ´»çƒ­ä¼‘å…‹ååº”ã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å¼€å‘äº†é›†æˆä¸´åºŠå’ŒåŸºå› ç»„æ•°æ®çš„é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œæ”¯æŒå¯¹æ‚£è€…äºšç»„å’Œç”Ÿå­˜ç»“æœçš„æ·±å…¥åˆ†æã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>çº³ç±³é¢—ç²’æŠ€æœ¯ä¼˜åŒ–CAR-Tç»†èƒå…ç–«æ²»ç–—ç­–ç•¥ï¼Œå…‹æœå®ä½“ç˜¤æŒ‘æˆ˜ã€‚</li><li>æ¢ç´¢åˆ†å­è¡¨å¾åœ¨å±€é™æ€§å°¤æ–‡è‚‰ç˜¤é¢„åè¯„ä¼°ä¸­çš„ä½œç”¨ã€‚</li><li>æ•´åˆå¤šé¡¹ä¸´åºŠè¯•éªŒæ•°æ®ï¼Œæ„å»ºé«“æ¯ç»†èƒç˜¤æ‚£è€…çš„ä¸´åºŠåŸºå› ç»„åˆ†æå¹³å°ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>é¦–æ¬¡æ„å»ºé«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œå®ç°ä¸´åºŠä¸åŸºå› ç»„æ•°æ®çš„ç»¼åˆæ¢ç´¢ã€‚</li><li>åˆ©ç”¨çº³ç±³é¢—ç²’å®ç°CAR-Tç»†èƒçš„ç²¾ç¡®é€’é€å’Œå…ç–«è°ƒèŠ‚ã€‚</li></ul><h3 id=-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æœ¬æ¬¡ç¤¾åŒºä¼šè®®èšç„¦äºâ€œGraceful Internet Packagesâ€ï¼Œæ—¨åœ¨æ¢è®¨å¦‚ä½•ä¼˜åŒ–äº’è”ç½‘æ•°æ®ä¼ è¾“æ•ˆç‡ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>äº’è”ç½‘æ•°æ®åŒ…çš„ä¼˜é›…ä¼ è¾“æœºåˆ¶</li><li>ç¤¾åŒºåä½œåœ¨ç½‘ç»œæŠ€æœ¯å‘å±•ä¸­çš„ä½œç”¨</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ï¼ˆæ–‡ç« æ‘˜è¦ä¿¡æ¯ä¸è¶³ï¼Œæ— æ³•æç‚¼å…·ä½“æŠ€æœ¯äº®ç‚¹ï¼‰</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
DirectRMæŠ€æœ¯é¦–æ¬¡å®ç°å¯¹è½¬å½•æœ¬å’Œåˆ†å­å†…å¤šé‡RNAä¿®é¥°ç›¸äº’ä½œç”¨çš„æ•´åˆæ£€æµ‹ï¼Œæ­ç¤ºRNAä¿®é¥°çš„å¤æ‚æ€§ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢å¤šé‡RNAä¿®é¥°åœ¨è½¬å½•æœ¬å’Œåˆ†å­å†…çš„ç›¸äº’ä½œç”¨ã€‚</li><li>æ­ç¤ºåº”æ¿€æ¿€ç´ å¦‚ä½•é€šè¿‡æŸ“è‰²è´¨ç»“åˆçš„lncRNAæ‹›å‹ŸPRC2ï¼Œæ²‰é»˜å…³é”®è„‘åŸºå› ï¼Œå»ºç«‹åº”æ¿€ä¿¡å·ä¸ç¥ç»å…ƒåŸºå› è¡¨è¾¾æ”¹å˜çš„è¡¨è§‚é—ä¼ é€šè·¯ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>DirectRMï¼šæ•´åˆæ€§ç›´æ¥RNAæµ‹åºæŠ€æœ¯ï¼Œç”¨äºæ£€æµ‹æ™¯è§‚å’Œå¤šé‡RNAä¿®é¥°é—´çš„ä¸²æ‰°ã€‚</li><li>RNAæµ‹åºï¼šç”¨äºæ­ç¤ºåº”æ¿€æ¿€ç´ æ²‰é»˜åŸºå› çš„æœºåˆ¶ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (23æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>ç ”ç©¶è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡æ–‡ç« å‡­ä»€ä¹ˆå‘åœ¨Immunityä¸Šï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€immunityã€ä»£è°¢</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç ”ç©¶è‚ é“èŒç¾¤ä»£è°¢ç‰©ä¸è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡æ–‡ç« å‡­ä»€ä¹ˆå‘åœ¨Immunityä¸Šï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=1&amp;sn=49fd27f887a1fc68219bdd737b041dda">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>æ–°æ€è·¯ï½œéå°ç»†èƒè‚ºç™Œçš„å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦åˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ç©ºé—´ç»„å­¦ã€è½¬å½•ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘æœ‰å°ä¼™ä¼´åæ˜ æ”¶ä¸åˆ°æ¨é€ï¼Œå› ä¸ºå…¬ä¼—å·æ”¹äº†æ¨é€ç®—æ³•ï¼Œç°åœ¨éœ€è¦åŠ æ˜Ÿæ ‡ï¼Œå¤šç‚¹èµã€ç‚¹åœ¨çœ‹ï¼Œæ‰èƒ½å‡†æ—¶æ”¶åˆ°æ¨é€å“¦ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523366&amp;idx=1&amp;sn=d10e332a7d7b0c7097793ad8b04ac45f">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>æœ€æ–°8.1åˆ†éè‚¿ç˜¤ç”Ÿä¿¡ï¼Œé’ˆå¯¹PANoptosisçƒ­ç‚¹è¿›è¡Œæœºå™¨å­¦ä¹ +å•ç»†èƒç­›é€‰+ç®€å•éªŒè¯ï¼Œå…¨æ–‡åªæœ‰4ä¸ªFigureï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247492984&amp;idx=1&amp;sn=afa1eeb1fd88acee0e552c4081f945e9">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>æœ€æ–°8.5åˆ†å•åŸºå› ç”Ÿä¿¡ï¼Œæ³›ç™Œ+å•ç»†èƒ+ç©ºè½¬+éªŒè¯ï¼Œå¤šç»„å­¦åˆ†æä¸€èµ·ä¸Šåˆ†ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€åŸºå› ç»„ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=1&amp;sn=027be6a51460a6f4dcfd2d69a5d6d8bf">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>è¿™ç¯‡Cellä¸»åˆŠå…³æ³¨â€œè¿åŠ¨-è‚ é“èŒç¾¤-ä»£è°¢ç‰©-æŠ—è‚¿ç˜¤å…ç–«â€ï¼Œæ€è·¯æ¸…æ™°ï¼Œè¯æ®æ‰å®ï¼Œé€»è¾‘å¤ªä¸¥è°¨äº†ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€ä»£è°¢</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè¿™ç¯‡æœ€æ–°çš„Cellä¸»åˆŠå…³æ³¨â€œè¿åŠ¨-è‚ é“èŒç¾¤-ä»£è°¢ç‰©-æŠ—è‚¿ç˜¤å…ç–«â€ï¼Œæ€è·¯æ¸…æ™°ï¼Œè¯æ®æ‰å®ï¼Œé€»è¾‘å¤ªä¸¥è°¨äº†ï¼</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=2&amp;sn=b68081d189d024cb27ad2a2b6c771789">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>å›½è‡ªç„¶å…³æ³¨è‚¿ç˜¤å…ç–«ï¼Œè¿™ç¯‡Immunityä¸Šçš„æ–‡ç« å¯ä»¥æä¾›ä¸€ä¸ªæ–°è§’åº¦â€¦â€¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€immunity</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šåŒæ ·æ˜¯åšè‚¿ç˜¤å…ç–«ï¼Œè¿™é¡¹ç ”ç©¶å‡­ä»€ä¹ˆå‘åœ¨Cellå­åˆŠImmunityä¸Šï¼Ÿå¦‚æœæ”¹æˆå›½è‡ªç„¶é¡¹ç›®ï¼Œä½ è§‰æ˜¯æ˜¯å¦åˆé€‚ï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821291&amp;idx=3&amp;sn=a1b57f89856d33170d92225f34fc3a05">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>è‚¿ç˜¤å…ç–«æ–°è§’åº¦ï¼šå¼•æµæ·‹å·´ç»“ä¸ºä½•æˆä¸ºç ”ç©¶çƒ­ç‚¹ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè‚¿ç˜¤å…ç–«æ–°è§’åº¦ï¼šå¼•æµæ·‹å·´ç»“ä¸ºä½•æˆä¸ºç ”ç©¶çƒ­ç‚¹ï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821291&amp;idx=1&amp;sn=e1767b662c7fe6fa971aad19dd2ca9b8">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>å¼ è€€é˜³å›¢é˜Ÿæ­ç¤ºTRIM28ä»‹å¯¼çš„SUMOåŒ–ä¿®é¥°è°ƒæ§åº”æ¿€é¢—ç²’åŠ¨æ€æ€§çš„æ–°æœºåˆ¶ | Cell Presså¯¹è¯ç§‘å­¦å®¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šCellPresså…¨ç§‘å­¦</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TME</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè¯¥ç ”ç©¶å·¥ä½œä¸ºè§£ææ¶²â€“æ¶²ç›¸åˆ†ç¦»ç›¸å…³ç”Ÿç‰©è¿‡ç¨‹æä¾›äº†æ–°çš„å·¥å…·ä¸æ€è·¯ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657180&amp;idx=1&amp;sn=e7a4ab9b1dfe988863f202f4a30e9281">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>Nature medicineåŒæ¬¾ | è«å…°è¿ªé…è‰²</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šåœ¨ç”Ÿä¿¡çš„å‘é‡ŒæŒ–å‘€æŒ–å‘€æŒ–</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè«å…°è¿ªé…è‰²ï¼Œå’Œç§‘ç ”ä¹Ÿæ²¾è¾¹å„¿çš„ï¼</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwODUyOTYzMw==&amp;mid=2247488593&amp;idx=1&amp;sn=cfa94ae01fc48e60b3e31cba3247a1eb">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>åŠŸèƒ½å¤±è°ƒçš„CD8 Tç»†èƒè½´çš„æŒç»­è¡¥å……ä¸æ™šæœŸä¹³è…ºç™ŒåŒ–å­¦å…ç–«æ²»ç–—çš„ååº”ç›¸å…³</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šé€šè¿‡æ•´åˆscRNA-seqä¸scTCR-seqæ•°æ®ï¼Œé«˜åˆ†è¾¨ç‡è§£æäº†åŒ–å­¦å…ç–«æ²»ç–—åœ¨è½¬ç§»æ€§ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¼•å‘çš„Tç»†èƒå…ç–«å›¾è°±é‡å¡‘ï¼Œæ­ç¤ºäº†ä»å…‹éš†å¢æ®–åˆ°è°±ç³»åˆ†åŒ–çš„åŠ¨æ€åº”ç­”è¿‡ç¨‹ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533526&amp;idx=1&amp;sn=bc403b317bd1a3ed3dd939e3f218d95a">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 13 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (44æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE294668 è„‰å†²å¼ 980 nm è¿‘çº¢å¤–å…‰ç”Ÿç‰©è°ƒèŠ‚é€šè¿‡è°ƒèŠ‚ Th2 ç»†èƒå› å­ååº”å’Œç‚ç—‡ç»†èƒæµ¸æ¶¦æ¥å‡è½» OVA è¯±å¯¼çš„è¿‡æ•æ€§å“®å–˜</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhengyi Wu ; Shih-Chin ChengSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPhotobiomodulation (PBM) is a non-invasive therapeutic strategy that uses specific light wavelengths to stimulate cellular processes that promote tissue repair, reduce inflammation, and alleviate pain. In this study, we evaluated the efficacy of a high-intensity 980 nm near-infrared (NIR) pulsed laser in a murine model of ovalbumin (OVA)-induced allergic asthma. In OVA-sensitized mice, typical allergic features were noted, including airway wall thickening, significant peribronchial and perivascular inflammatory cell infiltration, and compressed alveolar spaces. NIR PBM treatment markedly attenuated these histological changes. At the molecular level, PBM significantly downregulated type 2 cytokine gene expression, including IL-4, IL-5 and IL-13, in the lung tissue. Flow cytometry analyses further revealed that PBM reduced the infiltration of pulmonary eosinophils and inflammatory monocytes. Transcriptomic profiling coupled with gene set enrichment analysis (GSEA) indicated that PBM suppressed NF-ÎºB-mediated inflammatory signaling while modulating Th2-related responses. Collectively, our findings demonstrate that high-intensity 980 nm NIR PBM effectively mitigates key features of allergic asthma in a murine model, supporting its potential as a non-pharmacological, non-invasive adjunct therapy for asthma management.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294668">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE274105 å®¶çŠ¬å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ä»¥åŠçƒ­ä¼‘å…‹ååº”çš„å¿«é€Ÿé‡Šæ”¾ [PRO-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samu V Himanen ; Anniina VihervaaraSeries Type : OtherOrganism : Canis lupus familiarisDogs exhibit high genetic diversity due to extensive breeding, and provide a versatile model for genetics, evolution, and complex traits. While RNA synthesis and transcriptional architecture of promoters and enhancers have been extensively analyzed in human, mouse, and fly, little is known about the mechanisms that coordinate gene and enhancer transcription in dog. Here, we combine precision run-on sequencing (PRO-seq) and strand-specific mRNA-seq (mRNA-seq) to measure nascent transcription, mRNA expression and mRNA stability in golden retriever macrophage (DH82) cells. Tracking transcription at nucleotide-resolution uncovers the precise transcription start nucleotides (TSN) genome-wide, identifies the exact locations of promoters and transcribed enhancers, and quantifies transcription machineries at initiation, promoter proximal pause, gene bodies, and termination windows. Moreover, we trigger an instant transcriptional reprogramming using heat shock, and track at nucleotide-resolution, how dog cells coordinate RNA synthesis and mRNA expression across the genome. Taken together, this study describes the transcriptional landscape at nucleotide-resolution, measures RNA synthesis, mRNA expression and mRNA-stability, and identifies mechanisms of gene and enhancer reprogramming in Canis lupus familiaris.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274105">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE274106 å®¶çŠ¬å¯åŠ¨å­å’Œå¢å¼ºå­çš„è½¬å½•ç»“æ„ä»¥åŠçƒ­ä¼‘å…‹ååº”çš„å¿«é€Ÿé‡Šæ”¾ [mRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€Seuratã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Samu V Himanen ; Anniina VihervaaraSeries Type : Expression profiling by high throughput sequencingOrganism : Canis lupus familiarisDogs exhibit high genetic diversity due to extensive breeding, and provide a versatile model for genetics, evolution, and complex traits. While RNA synthesis and transcriptional architecture of promoters and enhancers have been extensively analyzed in human, mouse, and fly, little is known about the mechanisms that coordinate gene and enhancer transcription in dog. Here, we combine precision run-on sequencing (PRO-seq) and strand-specific mRNA-seq (mRNA-seq) to measure nascent transcription, mRNA expression and mRNA stability in golden retriever macrophage (DH82) cells. Tracking transcription at nucleotide-resolution uncovers the precise transcription start nucleotides (TSN) genome-wide, identifies the exact locations of promoters and transcribed enhancers, and quantifies transcription machineries at initiation, promoter proximal pause, gene bodies, and termination windows. Moreover, we trigger an instant transcriptional reprogramming using heat shock, and track at nucleotide-resolution, how dog cells coordinate RNA synthesis and mRNA expression across the genome. Taken together, this study describes the transcriptional landscape at nucleotide-resolution, measures RNA synthesis, mRNA expression and mRNA-stability, and identifies mechanisms of gene and enhancer reprogramming in Canis lupus familiaris.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274106">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE270168 GAPDH æ§åˆ¶è½¬å½•ç¨³å®šæ€§ã€è›‹ç™½è´¨ç¿»è¯‘å¹¶é©±åŠ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ç»†èƒå¢æ®– [CLIP-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€leukemiaã€TMEã€cardiacã€gliomaã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Scanpyã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : OtherOrganism : Homo sapiensDysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells.In acute myeloid leukemia (AML) RBPs are key regulators of tumor proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remains unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP) we are defining the global targetome detecting novel RNA targets mainly located within 5â€™UTR including GAPDH, RPL13a, PKM and ENO1. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we were able to demonstrate a stabilizing effect through the GAPDH binding to target transcripts including its own mRNA, unveiling GAPDHâ€™s pivotal role in cancer. The present findings provide new insights on the pathophysiological role of GAPDH in AML.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270168">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE308237 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ V</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Varun Katta ; Yichao Li ; Garret Manquen ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess genome-wide off-target activity of base editors and Cas9 nucleases identified by CHANGE-seq-BE, Digenome-seq, and CHANGE-seq, we performed hybrid capture sequencing for five therupatic loci (B2M, CBLB, CD7, CIITA, PDCD1) in human primary T-cells and PCSK9 in human hepatocytes. We observed high on-target editing for ABE, CBE, Cas9 mRNA edited cells and potential off-targets confirmed by hybrid capture sequencing. Our results demonstrate that CHANGE-seq-BE is highly sensitive than Digenome-seq to detect more bona fide off-targets with cellular activity ranging from 0.5% to 92.2%. Moreover, ABE exhibit more off-targets than Cas9 under same delivery conditions.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308237">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE307892 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ IV</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Varun Katta ; Yichao Li ; Garret Manquen ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess genome-wide off-target activity of base editors and Cas9 nucleases identified by CHANGE-seq-BE, Digenome-seq, and CHANGE-seq, we performed hybrid capture sequencing for five therupatic loci (B2M, CBLB, CD7, CIITA, PDCD1) in human primary T-cells and PCSK9 in human hepatocytes. We observed high on-target editing for ABE, CBE, Cas9 mRNA edited cells and potential off-targets confirmed by hybrid capture sequencing. Our results demonstrate that CHANGE-seq-BE is highly sensitive than Digenome-seq to detect more bona fide off-targets with cellular activity ranging from 0.5% to 92.2%. Moreover, ABE exhibit more off-targets than Cas9 under same delivery conditions.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307892">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE307740 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ III</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Cicera Lazzarotto ; Elizabeth Urbina ; GaHyun Lee ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo assess CHANGE-seq-BE performance, we used it to characterize ABE8e-NRCH base editor activity targeting sickle mutation (HBBS) in the HBB gene and identified additional 29 (53% more) bona fide off-targets than CIRCLE-seq. Furthermore, CHANGE-seq-BE applied for ABE8e targeting five therapeutically relevant loci (B2M, CBLB, CD7, CIITA, and PDCD1) in human primary T-cells and compared with Digenome-seq. CHANGE-seq-BE is highly sensitive and capable of detecting bona fide off-targets while requiring approximately 20-fold less sequencing reads.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307740">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE298534 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ II</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garret Manquen ; Varun Katta ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensTo adapt and apply for cytosone base editors (CBEs), we perfomed CHANGE-seq-BE using eA3A-BE3 to target B2M, CBLB, CD7, CIITA and PDCD1 regions at different loci. CHANGE-seq-BE identified low frequency off-target editing rates ranging from 1.7% to 7.5% that are not identified by Digenome-seq further implies CHANGE-seq-BE is highly sensitive and can identify true off-targets while requiring 20-fold fewer sequencing reads.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298534">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE298465 CHANGE-seq-BE èƒ½å¤ŸåŒæ—¶å¯¹ Cas ä¾èµ–æ€§ç¢±åŸºç¼–è¾‘å™¨çš„å…¨åŸºå› ç»„è„±é¶æ´»æ€§è¿›è¡Œçµæ•ä¸”æ— åå€šçš„ä½“å¤–åˆ†æ I</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€TCGAã€sequencingã€Hi-Cã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Garret Manquen ; Varun Katta ; Yichao Li ; Shengdar TsaiSeries Type : OtherOrganism : Homo sapiensBy CHANGE-seq-BE, we identified a total of 81 potential off-targets and confirmed 95.4% frequencies of on-target editing with no evident off-targets above the detection threshold compared to controls (rhAmp-seq, IDT).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298465">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE270169 GAPDH æ§åˆ¶è½¬å½•æœ¬ç¨³å®šæ€§ã€è›‹ç™½è´¨ç¿»è¯‘å¹¶é©±åŠ¨æ€¥æ€§é«“ç³»ç™½è¡€ç—…ç»†èƒå¢æ®– [GAPDH_KD_RNAseq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€leukemiaã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€DepMapã€depmapã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€transcriptomeã€proteomeã€R packageã€Scanpyã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells.In acute myeloid leukemia (AML) RBPs are key regulators of tumor proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remains unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP) we are defining the global targetome detecting novel RNA targets mainly located within 5â€™UTR including GAPDH, RPL13a, PKM and ENO1. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we were able to demonstrate a stabilizing effect through the GAPDH binding to target transcripts including its own mRNA, unveiling GAPDHâ€™s pivotal role in cancer. The present findings provide new insights on the pathophysiological role of GAPDH in AML.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270169">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 34 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> <strong>åŸºäºçº³ç±³é¢—ç²’çš„ CAR-T ç»†èƒå…ç–«æ²»ç–—ç­–ç•¥ï¼šæŒ‘æˆ˜ã€å½±å“å’Œå‰æ™¯</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: åµŒåˆæŠ—åŸå—ä½“ï¼ˆCARï¼‰-T ç»†èƒç–—æ³•åœ¨æ²»ç–—è¡€æ¶²ç³»ç»Ÿæ¶æ€§è‚¿ç˜¤æ–¹é¢å–å¾—äº†æ˜¾è‘—è¿›å±•ï¼Œä½†å…¶æ›´å¹¿æ³›çš„åº”ç”¨é¢ä¸´ç€åˆ¶é€ å¤æ‚æ€§ã€å®ä½“ç˜¤å¾®ç¯å¢ƒå±éšœå’Œå…ç–«æ¯’æ€§ç­‰æŒ‘æˆ˜ã€‚çº³ç±³é¢—ç²’ ï¼ˆNPï¼‰ åˆ©ç”¨å…¶ç²¾ç¡®é€’é€ã€å…ç–«è°ƒèŠ‚å’Œå¤šåŠŸèƒ½æ•´åˆèƒ½åŠ›ï¼Œä¸ºä¼˜åŒ– CAR-T ç»†èƒç–—æ³•æä¾›äº†åˆ›æ–°ç­–ç•¥ã€‚æœ¬æ–‡å…¨é¢é˜æ˜äº† CAR-T ç»†èƒæ²»ç–—çš„åŸºæœ¬æ¡†æ¶å’Œè‚¿ç˜¤å­¦åº”ç”¨ä¸­çš„æŒ‘æˆ˜ã€‚éšåï¼Œç³»ç»Ÿæ€»ç»“äº† NPs ä¸ CAR-T ç»†èƒæ²»ç–—çš„ååŒæœºåˆ¶ï¼ŒåŒ…æ‹¬ä¼˜åŒ–åŸºå› ä¿®é¥°ã€å¢å¼ºè‚¿ç˜¤éƒ¨ä½æµ¸æ¶¦ã€è°ƒèŠ‚å…ç–«æŠ‘åˆ¶è‚¿ç˜¤å¾®ç¯å¢ƒã€å‡è½»è‚¿ç˜¤æŠ—åŸå¼‚è´¨æ€§ã€å®æ—¶ç›‘æµ‹å’ŒåŠ¨æ€æ§åˆ¶ç»†èƒæ´»æ€§ã€‚æœ€ç»ˆï¼Œå®ƒå¼ºè°ƒäº†è¯¥é¢†åŸŸå†…äººå·¥æ™ºèƒ½é›†æˆçš„æ–°å…´èŒƒå¼ï¼ŒåŒæ—¶è®¨è®ºäº†è¿™ç§è”åˆæ²»ç–—æ–¹æ³•çš„ç›¸å…³æŠ€æœ¯éšœç¢å’Œæœªæ¥å‰æ™¯ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985998009503752192/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>åˆ†å­è¡¨å¾ä¸ºå±€é™æ€§å°¤æ–‡è‚‰ç˜¤æ‚£è€…çš„é¢„åæä¾›ä¿¡æ¯ï¼šå„¿ç«¥è‚¿ç˜¤å­¦ç»„çš„æŠ¥å‘Š</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸´åºŠè‚¿ç˜¤å­¦æ‚å¿—ï¼Œå°åˆ·å‰ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985945830529081344/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·èƒ½å¤Ÿç»¼åˆæ¢ç´¢æ‚£è€…çš„ä¸´åºŠå’ŒåŸºå› ç»„æ•°æ®</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: é«“æ¯ç»†èƒç˜¤æ˜¯ä¸€ç§æ™®éçš„ã€é«˜åº¦å¼‚è´¨æ€§çš„æ¶æ€§å°å„¿è„‘ç™Œã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œæˆ‘ä»¬å¼€å‘äº†é«“æ¯ç»†èƒç˜¤èŸèƒåˆ†æé—¨æˆ·ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºç½‘ç»œçš„æ•°æ®åˆ†æå’Œå¯è§†åŒ–å¹³å°ï¼Œæ•´åˆäº†æ¥è‡ªä¸‰é¡¹ä¸»è¦ä¸´åºŠè¯•éªŒï¼ˆACNS0331ã€ACNS0332 å’Œ SJMB03ï¼‰çš„ 898 åæ‚£è€…çš„ä¸´åºŠã€åˆ†å­å’Œç”Ÿå­˜æ•°æ®ã€‚è¯¥é—¨æˆ·ç½‘ç«™å°†ä¸´åºŠæ•°æ®ä¸åŸºå› ç»„çªå˜å’Œ DNA ç”²åŸºåŒ–ç»„ç›¸ç»“åˆï¼Œèƒ½å¤Ÿå¯¹è‚¿ç˜¤äºšç»„å’Œç”Ÿå­˜ç»“æœè¿›è¡Œæ·±å…¥åˆ†æã€‚è¯¥é—¨æˆ·ç”± ProteinPaint æ¡†æ¶æä¾›æ”¯æŒçš„ç”¨æˆ·å‹å¥½å‹å¯è§†åŒ–å·¥å…·ä½¿è¿™äº›æ•°æ®çš„åŠ¨æ€æ¢ç´¢å’Œè‡ªå®šä¹‰åˆ†å±‚æˆä¸ºå¯èƒ½ï¼Œå…è®¸ç”¨æˆ·ä»å„ç§å˜é‡ä¸­è¿›è¡Œé€‰æ‹©æˆ–è‡ªå®šä¹‰è‡ªå·±çš„å˜é‡ã€‚é—¨æˆ·ä¸­çš„ Cox å›å½’åˆ†æå·¥å…·åœ¨æ£€æŸ¥å¼‚æ„æ•°æ®é›†ä¸­å˜é‡çš„é¢„åå½±å“æ–¹é¢è¡¨ç°å‡ºæ•ˆç”¨ã€‚æ­¤å¤–ï¼Œå¯¹æºå¸¦ KBTBD4 çªå˜çš„é«“æ¯ç»†èƒç˜¤åŠå…¶ç›¸åº”ç”²åŸºåŒ–ç»„çš„æ·±å…¥ç ”ç©¶äº§ç”Ÿäº†æœ‰åŠ©äºæ”¹è¿›åˆ†å­åˆ†ç±»çš„å…ˆå¯¼ã€‚è¿™äº›ç”¨ä¾‹å¼ºè°ƒäº†è¯¥é—¨æˆ·ç½‘ç«™åœ¨å¢å¼ºé£é™©åˆ†å±‚ã€ä¸ºé‡èº«å®šåˆ¶çš„æ²»ç–—ç­–ç•¥æä¾›ä¿¡æ¯ä»¥åŠæ­ç¤ºé«“æ¯ç»†èƒç˜¤æ‚£è€…åˆ†å­å¼‚è´¨æ€§</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1986188924621070336/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¼˜é›…çš„ç½‘ç»œå¥—é¤</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šR package</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šHow to join this free online event with Salix Dubois, Tan Ho and Matthias GreniÃ©. Join us for our next Community Call, â€œGraceful Internet Packages,â€ featuring Matthias, Tan, and Salix. In this session, weâ€™ll explore how to design and maintain R packag&mldr; Continue reading: Graceful Internet Packages</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/11/graceful-internet-packages/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>DirectRMâ€”â€”åˆ©ç”¨ç›´æ¥RNAæµ‹åºæŠ€æœ¯å¯¹å¤šç§RNAä¿®é¥°è¿›è¡Œæ•´åˆæ£€æµ‹ï¼Œä»è€Œæ­ç¤ºå…¶é—´çš„ç›¸äº’ä½œç”¨å’Œç‰¹å¾ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€TMEã€cardiacã€kinaseã€TCGAã€sequencingã€RNAseqã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€R packageã€Seurat</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing with DirectRM reveals how multiple RNA modifications interact within transcripts and molecules, offering a new way to explore the complexity of the&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/directrm-integrated-detection-of-landscape-and-crosstalk-between-multiple-rna-modifications-using-direct-rna-sequencing/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>ç ”ç©¶æ­ç¤ºï¼Œå‹åŠ›æ¿€ç´ é€šè¿‡æŸ“è‰²è´¨ç»“åˆçš„RNAæŠ‘åˆ¶å…³é”®è„‘åŸºå› çš„è¡¨è¾¾ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€TMEã€kinaseã€TCGAã€scRNAã€scDNAã€genomeã€Seuratã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing reveals how stress hormones trigger chromatin silencing through lncRNAs that recruit PRC2, uncovering an epigenetic pathway linking stress signaling to altered neuronal gene expression&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/stress-hormones-silence-key-brain-genes-through-chromatin-bound-rnas-study-reveals/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>ä¸´åºŠNGSç§‘å­¦ä¸»ä»»</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€scDNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šMemorial Sloan Kettering is hiring a Scientific Director of Clinical NGS to advance RNA sequencing and NGS-based cancer diagnostics, enabling precise tumor profiling, non-invasive testing, and personalized treatment strategies&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/scientific-director-of-clinical-ngs-2/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>TME</td><td>44</td></tr><tr><td>scRNA</td><td>41</td></tr><tr><td>genome</td><td>41</td></tr><tr><td>scDNA</td><td>34</td></tr><tr><td>scATAC</td><td>34</td></tr><tr><td>Seurat</td><td>30</td></tr><tr><td>cancer</td><td>28</td></tr><tr><td>glioma</td><td>28</td></tr><tr><td>TCGA</td><td>24</td></tr><tr><td>genomics</td><td>23</td></tr><tr><td>spatial</td><td>23</td></tr><tr><td>proteome</td><td>22</td></tr><tr><td>tumor</td><td>21</td></tr><tr><td>cardiac</td><td>21</td></tr><tr><td>histone</td><td>19</td></tr><tr><td>Scanpy</td><td>18</td></tr><tr><td>carcinoma</td><td>17</td></tr><tr><td>resistance</td><td>12</td></tr><tr><td>Hi-C</td><td>12</td></tr><tr><td>DepMap</td><td>12</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (13æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484012&amp;idx=1&amp;sn=5c59e1918da067d66af9bbff3ff813e4">è¯¦è§£ï¼šé…®ä½“ä»£è°¢</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=3&amp;sn=009cfa503cdfb0e641167246eebf8485">æœ€æ–°9.4åˆ†å•åŸºå› çº¯ç”Ÿä¿¡ï¼Œç»å…¸çš„æ€è·¯ä¸ºä½•èƒ½å‘è¡¨è¿™ä¹ˆé«˜åˆ†ï¼Œä½ è¡Œä½ ä¹Ÿä¸Šï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503864&amp;idx=2&amp;sn=27cd89a630ef708561956df398714ed4">è°è¯´å•åŸºå› æ²¡å‰é€”ï¼Œç»“åˆå•ç»†èƒï¼Œç©ºè½¬å’Œå®éªŒéªŒè¯ï¼Œç…§æ ·å‘8åˆ†1åŒºæ–‡ç« ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490327&amp;idx=1&amp;sn=d471c2e56177e8f57861377dabbdb860">Science|å•ç»†èƒ2.0æ—¶ä»£æ¥äº†ï¼šPerturb-seqåœ¨ä½“åº”ç”¨é¦–ç§€ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493109&amp;idx=1&amp;sn=e31b38258a9a3606f9a5221af5528644">metasens åŒ…ç”¨äº metaåˆ†æä¸­çš„æ•æ„Ÿæ€§åˆ†æ:æé™Metaåˆ†æï¼ˆLimit meta-analysisï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU0ODQyNjQxOA==&amp;mid=2247554767&amp;idx=1&amp;sn=db3c31dc17c1ac957c819d0c310ee341">Nature ï½œ â€œåŸºå› æ˜¾å¾®é•œâ€çµæ•åº¦æå‡ç™¾å€ï¼Œé¦–æ¬¡ç»˜åˆ¶å¥åº·äººç™Œç—‡çªå˜å…¨æ™¯å›¾</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821290&amp;idx=3&amp;sn=50ce5e953111c0121a42409b9c8feefb">Cellä¸¤ç¯‡20.6åˆ†å­åˆŠï¼šçœ‹è‚ é“èŒç¾¤åˆ†åˆ«å¦‚ä½•é€šè¿‡è›‹ç™½å’Œä»£è°¢ç‰©å‘æŒ¥ä¿ƒç™Œä½œç”¨ï¼Ÿ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657180&amp;idx=3&amp;sn=938733197e4399064f7a8e2a167cc3d1">åŒæµå¤§å­¦é«˜äºšå¨/é«˜ç»è£/ç‹è¯‘è±å›¢é˜ŸCell Stem Cellï¼šæ­ç¤ºmâ¶Aä¿®é¥°é™åˆ¶äººç±»èƒšèƒå¹²ç»†èƒå…¨èƒ½æ€§çš„æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509004&amp;idx=3&amp;sn=ffbe2d88a9431c184ed32be07dcd8a3d">çªç ´è€è¯å›°å¢ƒï¼ä¸­å›½åŒ»å­¦ç§‘å­¦é™¢å¼€è¾Ÿé£Ÿç®¡é³ç™Œæ²»ç–—å…¨æ–°è·¯å¾„</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509004&amp;idx=1&amp;sn=ac15b1e52f8319bb9d595787543dfb2b">è¶…è¶Šä¼ ç»Ÿåˆ†æœŸç³»ç»Ÿï¼æ–°æ–¹æ³•æ˜¾ç€æå‡éå°ç»†èƒè‚ºç™Œé£é™©åˆ†å±‚å‡†ç¡®æ€§ï¼Œç ´è§£è‚¿ç˜¤å¾®ç¯å¢ƒç»†èƒç©ºé—´æ’åˆ—å¯†ç </a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649496&amp;idx=5&amp;sn=6d64ab8be4e3d1a23fa3f2ae194ddde7">IF 29 | æ¸…åå¤§å­¦/å±±ä¸œå¤§å­¦åˆä½œæ­ç¤ºè°ƒæ§äººç±»èƒšèƒåŸºå› ç»„æ¿€æ´»å’Œæ—©æœŸå‘è‚²æ–°é¶ç‚¹</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649496&amp;idx=2&amp;sn=6d73470235d5f0eb0ff9928e523f337d">è‚¿ç˜¤è®ºæ–‡æŠ•ç¨¿ä¸‰å¤§éšå½¢é£é™©ä¸åˆè§„çº¢çº¿ï¼Œé¡¶åˆŠå‰¯ä¸»ç¼–æ‰‹æŠŠæ‰‹æ•™ä½ é¿å‘</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxOTI0Mjc3Mw==&amp;mid=2247496498&amp;idx=1&amp;sn=b4b09bfa70b0523ccd3522945210b497">è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒ(TAMs)ç®€è¦æ¦‚è¿°</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (34æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217432">GSE217432 å¯¹åˆ†æ³Œè„‚è‚ªé…¸çš„è§£è„‚è€¶æ°é…µæ¯èŒçš„æ¯”è¾ƒè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºäº†ç»†èƒå£è›‹ç™½çš„é‡è¦æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274063">GSE274063 é‰´å®šæ–‘é©¬é±¼ä¸­æ§åˆ¶å†…èƒšå±‚å½¢æˆå’Œå·¦å³æ¨¡å¼çš„é‡å¤SOXå› å­åŠŸèƒ½åˆ†åŒ–çš„åˆ†å­åŸºç¡€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268442">GSE268442 ç¼ºè¡€æ€§å’ä¸­å¤§é¼ åŠ¨è„‰å†…ç§»æ¤äººç¥ç»å¹²ç»†èƒåç»†èƒå¤–å›Šæ³¡è½¬å½•ç»„ï¼ˆmicroRNAï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303861">GSE303861 ç”Ÿé•¿å› å­FGF21é€šè¿‡ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶HDAC4ç»´æŒå»ç¥ç»æ”¯é…å¼•èµ·çš„éª¨éª¼è‚Œèç¼©ä¸­çš„ç¥ç»è‚Œè‚‰æ¥å¤´</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302582">GSE302582 çŸ­è·‘é—´æ­‡è®­ç»ƒé©±åŠ¨äººç±»ç‹¬ç‰¹çš„çº¿ç²’ä½“åº”æ¿€ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309046">GSE309046 ä½“å†…æŠ—FAP CAR-Tç–—æ³•å¯å‡å°‘ä»£è°¢åŠŸèƒ½éšœç¢ç›¸å…³æ€§è„‚è‚ªæ€§è‚ç‚ä¸­çš„çº¤ç»´åŒ–å¹¶æ¢å¤è‚è„ç¨³æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274809">GSE274809 ä½ caspase 8 è¡¨è¾¾ä¿ƒè¿›ç¥ç»å…ƒç¥–ç»†èƒæ‹Ÿæ€å’Œå°ç»†èƒè‚ºç™Œè½¬ç§»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274232">GSE274232 ä½ caspase 8 è¡¨è¾¾ä¿ƒè¿›ç¥ç»å…ƒç¥–ç»†èƒæ‹Ÿæ€å’Œå°ç»†èƒè‚ºç™Œè½¬ç§»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306775">GSE306775 åœ¨ HAP1 MTHFD1-K56R ç»†èƒä¸­è¿›è¡Œå…¨åŸºå› ç»„ CRISPR æ•²é™¤ç­›é€‰ï¼Œä»¥é‰´å®šèµ‹äºˆæŠ—è…ºè‹·æ¯’æ€§çš„åŸºå› </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299897">GSE299897 GW9662ï¼Œä¸€ç§è¿‡æ°§åŒ–ç‰©é…¶ä½“å¢æ®–æ¿€æ´»å—ä½“Î³ (PPARÎ³) æŠ‘åˆ¶å‰‚ï¼Œä¼šæŸå®³æ–‘é©¬é±¼çš„æ—©æœŸèƒšèƒå‘è‚²ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281261">GSE281261 é’¨è¢«ä¸€ç§ä¼˜åŠ¿äººç±»è‚ é“å¾®ç”Ÿç‰©â€”â€”é»æ¶²çœŸæ†èŒï¼ˆEubacterium limosumï¼‰ç”¨äºä¹³é…¸æ¶ˆè€—å’ŒçŸ­é“¾è„‚è‚ªé…¸ï¼ˆSCFAï¼‰ç”Ÿæˆã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305038">GSE305038 å•æ—¥æ´»åŠ¨é‡å‡å°‘ä¼šæ”¹å˜æ¬¡æ—¥çš„è½¬å½•ç»„å’Œä»£è°¢è¿åŠ¨ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281233">GSE281233 GPC2-CAR T ç»†èƒå¯¹åŸä½é«“æ¯ç»†èƒç˜¤å¼‚ç§ç§»æ¤å…·æœ‰å¼ºå¤§çš„ä¸´åºŠå‰æ´»æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287760">GSE287760 é›„æ¿€ç´ å—ä½“é©±åŠ¨å¤šèƒºåˆæˆï¼Œä»è€Œå¢åŠ æ‚£å‰åˆ—è…ºç™Œçš„é£é™©</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240493">GSE240493 é‡å¤è¡Œä¸ºæµ‹è¯•å’Œæ±‡æ€»æŒ‡æ ‡çš„ä½¿ç”¨æ­ç¤ºäº†ä¸´åºŠå‰å•®é½¿åŠ¨ç‰©æ¨¡å‹ä¸­çš„ç‰¹è´¨ç„¦è™‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308047">GSE308047 å‡è¡€é…¶åˆºæ¿€çš„è‚æ˜ŸçŠ¶ç»†èƒä¸­æ–°å‹åŸºå› è¡¨è¾¾ç¨‹åºçš„é‰´å®š</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245166">GSE245166 æ‹Ÿå—èŠ¥é˜³ç¦»å­æ°¨åŸºé…¸è½¬è¿è›‹ç™½ (CAT) æ˜¯ä¸€ç§å¯¹å†…å¸æ€§é™¤è‰å‰‚ L-è†¦ä¸èŒç´ å…·æœ‰é«˜äº²å’ŒåŠ›çš„è½¬è¿è›‹ç™½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302398">GSE302398 æ­ç¤ºPPARÎ³å’Œå…ç–«è›‹ç™½é…¶ä½“åœ¨ILC2è°ƒæ§ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296941">GSE296941 è±èŒµè¡£è—»â€œé‡ç”Ÿå‹â€èŒæ ªåŸºç¡€è½¬å½•ç»„çš„å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270329">GSE270329 AINTEGUMENTA ç£·é…¸åŒ–å¼€å…³æ§åˆ¶æ¬¡çº§ç”Ÿé•¿è¿‡ç¨‹ä¸­åŒä¾§å¹²ç»†èƒçš„æ´»æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303964">GSE303964 ä¸æ°¨é…¸ tRNA ç«äº‰è°ƒæ§ä¸æ°¨é…¸æ•æ„Ÿå¯†ç å­çš„ mRNA ç¿»è¯‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237016">GSE237016 APOBEC3 é€šè¿‡ IL1A/AP-1 ä¿¡å·é€šè·¯ä¿ƒè¿›é³çŠ¶ç»†èƒåˆ†åŒ–å’Œè½¬ç§»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271260">GSE271260 ç¥ç»å…ƒå‰ä½“ç»†èƒæ‹Ÿæ€é©±åŠ¨å°ç»†èƒè‚ºç™Œè½¬ç§»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307666">GSE307666 eIF3d å’Œ eIF3e ä»‹å¯¼å¯¹ç¼ºæ°§çš„é€‰æ‹©æ€§ç¿»è¯‘è°ƒæ§ï¼Œè¿™ç§è°ƒæ§å¯è¢«å°åˆ†å­æŠ‘åˆ¶ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169493">GSE169493 å½±å“çƒ­å¸¦çº¸èœ‚ï¼ˆPolistes canadensisï¼‰æˆè™«è¡Œä¸ºå˜å¼‚çš„å› ç´ </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294234">GSE294234 äººç±»æ­»åç»„ç»‡æ ·æœ¬çš„å…¨åŸºå› ç»„ç”²åŸºåŒ–è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE213241">GSE213241 VHLçªå˜ç»†èƒçš„é—ä¼ æ˜“æ„Ÿæ€§ç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288481">å°é¼ è‚ é“ Pdgfra+ ç»†èƒçš„ GSE288481 å•ç»†èƒ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280922">GSE280922 åšæ¥éœ‰ç´ æŸä¼¤å°é¼ è‚ºçš„å•ç»†èƒRNAæµ‹åºåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306269">GSE306269 èŒæ ªå¾ˆé‡è¦ï¼šå®¿ä¸»ååº”åæ˜ äº†é±¿é±¼-å¼§èŒå…±ç”Ÿä½“ä¸­çš„å…±ç”Ÿä½“èµ·æº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281841">GSE281841 å¤–å‘¨åŠ¨è„‰ç–¾ç—…ç‹­çª„1çº§ä¸4çº§å’Œ5çº§æ‚£è€…çš„åŸºå› è¡¨è¾¾æ•°æ®</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250516">GSE250516 IAF scRNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250515">GSE250515 GLIS3 RNA-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250514">GSE250514 GLIS3 ChIP-seq</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-06 21:41</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week452025/ rel=tag>Week452025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-06/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-06</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-08/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-08</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-11/>ç§‘ç ”æ—¥æŠ¥ 2026-01-11</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-10/>ç§‘ç ”æ—¥æŠ¥ 2026-01-10</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-09/>ç§‘ç ”æ—¥æŠ¥ 2026-01-09</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-08/>ç§‘ç ”æ—¥æŠ¥ 2026-01-08</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-07/>ç§‘ç ”æ—¥æŠ¥ 2026-01-07</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (74)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (74)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>